Nephrology




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order

Issue Information

doi : 10.1111/nep.14059

Volume 28, Issue 8

Buy The Package and View The Article Online


Practical considerations for the use of SGLT-2 inhibitors in the Asia–Pacific countries�An expert consensus statement

Adrian Liew, Aida Lydia, Bien J. Matawaran, Paweena Susantitaphong, Huong Thi Bich Tran, Lee Ling Lim

doi : 10.1111/nep.14167

Recent clinical studies have demonstrated the effectiveness of SGLT-2 inhibitors in reducing the risks of cardiovascular and renal events in both patients with and without type 2 diabetes mellitus. Consequently, many international guidelines have begun advocating for the use of SGLT-2 inhibitors for the purpose of organ protection rather than as simply a glucose-lowering agent.

Buy The Package and View The Article Online


Is metabolic-dysfunction-associated fatty liver disease or advanced liver fibrosis associated with erythropoietin stimulating agent hypo-responsiveness among patients with end-stage kidney disease on haemodialysis?

Wei-Kei Wong, Wah-Kheong Chan, Shubash Ganapathy, Soo-Kun Lim

doi : 10.1111/nep.14186

This study aims to determine if metabolic-dysfunction-associated fatty liver disease (MAFLD) or advanced liver fibrosis is associated with erythropoietin stimulating agent (ESA) hypo-responsiveness in hemodialysis patients.

Buy The Package and View The Article Online


Estimating baseline creatinine to detect acute kidney injury in patients with chronic kidney disease

Thomas Larsen, Emily J. See, Natasha E. Holmes, Rinaldo Bellomo

doi : 10.1111/nep.14191

Accurately estimating baseline kidney function is essential for diagnosing acute kidney injury (AKI) in patients with chronic kidney disease (CKD). We developed and evaluated novel equations to estimate baseline creatinine in patients with AKI on CKD.

Buy The Package and View The Article Online


A retrospective database analysis of erythropoiesis-stimulating agent treatment patterns and associated healthcare resource use in patients with non–dialysis-dependent chronic kidney disease–related anaemia in Japan

Sari Mishina, Miina Waratani, Satoshi Onozawa, Hiroyuki Okumura, Yuichiro Ito, Yoshinari Yasuda

doi : 10.1111/nep.14168

This study was conducted to evaluate clinical characteristics, treatment patterns, and healthcare resource use (HCRU) for patients in Japan with non–dialysis-dependent chronic kidney disease (CKD) and anaemia.

Buy The Package and View The Article Online


Financial toxicity experienced by rural Australian families with chronic kidney disease

Nicole Scholes-Robertson, Katrina Blazek, Allison Tong, Talia Gutman, Jonathan C. Craig, Beverley M. Essue, Kirsten Howard, Germaine Wong, Martin Howell

doi : 10.1111/nep.14192

Chronic kidney disease (CKD) and its treatment places a financial burden on healthcare systems and households worldwide, yet little is known of its financial impact, on those who reside in rural settings. We aimed to quantify the financial impacts and out-of-pocket expenditure experienced by adult rural patients with CKD in Australia.

Buy The Package and View The Article Online


Cecal volvulus: A rare cause of intestinal obstruction after peritoneal dialysis catheter insertion

Qinghua Yang, Jiaxiang Ding, Yankai Zhang, Ning Ning, Mei Wang

doi : 10.1111/nep.14172

Buy The Package and View The Article Online


Oxalate nephropathy in ataxia telangiectasia – A case report

Leonie R. Perera, Edmund Y. M. Chung, Sarah Roxburgh

doi : 10.1111/nep.14173

Buy The Package and View The Article Online


Utility of post-transplant native nephrectomy in children with nephropathic cystinosis: A single centre retrospective study

Ratna Acharya, Rachel Bush, Felicia Johns, Kiran Upadhyay

doi : 10.1111/nep.14189

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?